Adapting Analytical & QC Strategies for Emerging RNA Modalities to Ensure Robust Characterization & Release

  •  How evolving RNA modalities like circular and self-amplifying RNA are reshaping analytical design and QC readiness
  • Translating flexible R&D assays into GMP-compliant QC methods without compromising analytical sensitivity
  • Balancing innovation and standardization to build adaptable yet regulator-ready analytical frameworks for next-generation RNA therapeutics